Dynavax Technologies Corporation
Feb 26, 2013

Dynavax to Present at the Cowen and Company 33rd Annual Healthcare Conference

BERKELEY, CA -- (Marketwire) -- 02/26/13 -- Dynavax Technologies Corporation (NASDAQ: DVAX) announced today that it will present at the Cowen and Company 33rd Annual Healthcare Conference in Boston on Tuesday, March 5, 2013 at 8:40 a.m. Eastern Time (5:40 a.m. Pacific Time).

Dino Dina, M.D., Chief Executive Officer of Dynavax, will provide a company overview. To access the slide presentation, live webcast, and subsequent archived recording, please visit Dynavax's website at http://investors.dynavax.com/newsevents.cfm.

About Dynavax

Dynavax, a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious and inflammatory diseases. Dynavax's lead product candidate is HEPLISAV , a Phase 3 investigational adult hepatitis B vaccine. For more information visit www.dynavax.com.


Michael Ostrach

Vice President and Chief Business Officer


Email Contact

Source: Dynavax Technologies

News Provided by Acquire Media